Physician profile
Jared Myers
NPI 1750673638
$7,274.83
in general payments reported to CMS, 2019-2025
22 companies · $1,185 in 2025
The $1,185 reported for 2025 was more than what 76% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $883 · 2020: $306 · 2021: $462 · 2022: $841 · 2023: $1,626 · 2024: $1,972 · 2025: $1,185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,783.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,175.73 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $640.65 | 2019-2025 | Intracept |
| Medtronic USA, INC. | $549.29 | 2019 | |
| Abbott Laboratories | $421.85 | 2019-2025 | Proclaim, Eterna |
| Nevro Corp. | $332.16 | 2020-2024 | Senza |
| Merz Pharmaceuticals, LLC | $199.89 | 2022-2025 | Xeomin |
| Abbvie INC. | $197.09 | 2022-2025 | |
| Globus Medical, INC. | $177.02 | 2025 | Senza, Vyrsa V1 |
| Allergan, INC. | $121.45 | 2019-2022 | |
| Si-Bone, INC. | $105.94 | 2021-2024 | |
| Ibsa Pharma INC. | $96.39 | 2023 | Licart |
| Spr Therapeutics, INC | $40.58 | 2019-2025 | Sprint Pns System |
| Saluda Medical Americas, INC. | $35.64 | 2024 | Evoke |
| Ermi LLC | $30.86 | 2019 | |
| Stryker Corporation | $28.00 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $26.44 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.43 | 2019 | |
| Curonix LLC | $17.30 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Teva Pharmaceuticals USA, INC. | $17.00 | 2020 | |
| Biotronik Nro, INC. | $15.07 | 2024 | Prospera |
| Biodelivery Sciences International, INC. | $14.87 | 2020 | |
| Tenex Health INC. | $14.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Myers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.